Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.316
+0.130 (10.96%)
At close: Mar 4, 2026
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 60.12 million as of March 4, 2026. Its market cap has decreased by -43.17% in one year.
Market Cap
60.12M
Enterprise Value
44.22M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.32
Market Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 60.12M, a decrease of -58.36%. That is a compound annual growth rate of -17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 60.12M | -30.66% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | 144.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 101.59M |
| Biosergen AB | 90.17M |
| Scandinavian ChemoTech AB | 89.09M |
| OncoZenge AB | 82.32M |
| Spago Nanomedical AB | 78.07M |
| Alzinova AB | 64.05M |
| AcouSort AB | 50.16M |
| 2cureX AB | 40.29M |